Paliperidone (Invega) manufacturer withdraws application for its use in bipolar disorder
Reproduction of EMEA’s press release about the Janssen-Cilag International application withdrawal for an extension of indication for Invega (paliperidone): PRESS RELEASE Janssen-Cilag International N.V. withdraws its application for an extension of indication for Invega (paliperidone) The European Medicines Agency (EMEA) has been formally notified by Janssen-Cilag International N.V. of its decision to withdraw its application […]